相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment
Ganesh Venkatraman et al.
FASEB JOURNAL (2015)
Aldehyde dehydrogenases in cancer: an opporunity for biomaker and drug development?
Klaus Pors et al.
DRUG DISCOVERY TODAY (2014)
Ovarian cancer stem cells: Are they real and why are they important?
Monjri M. Shah et al.
GYNECOLOGIC ONCOLOGY (2014)
Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets
Nuzhat Ahmed et al.
MOLECULAR ASPECTS OF MEDICINE (2014)
Lysophosphatidic Acid (LPA) Signaling in Human and Ruminant Reproductive Tract
Izabela Woclawek-Potocka et al.
MEDIATORS OF INFLAMMATION (2014)
ALDH1A1 Maintains Ovarian Cancer Stem Cell-Like Properties by Altered Regulation of Cell Cycle Checkpoint and DNA Repair Network Signaling
Erhong Meng et al.
PLOS ONE (2014)
Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?
Christen L Walters Haygood
World Journal of Stem Cells (2014)
Autotaxin in embryonic development
Wouter H. Moolenaar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: A focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays
Semjon Willier et al.
BIOLOGY OF THE CELL (2013)
Ovarian cancer stem cells: Working towards the root of sternness
Rosemary Foster et al.
CANCER LETTERS (2013)
SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma
Petra M. Bareiss et al.
CANCER RESEARCH (2013)
Autotaxin-Lysophosphatidic Acid Signaling Axis Mediates Tumorigenesis and Development of Acquired Resistance to Sunitinib in Renal Cell Carcinoma
Shih-Chi Su et al.
CLINICAL CANCER RESEARCH (2013)
Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
Adam D. Steg et al.
CLINICAL CANCER RESEARCH (2012)
Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance
Nasser Samadi et al.
BIOCHIMIE (2011)
Autotaxin and LPA receptor signaling in cancer
Anna J. S. Houben et al.
CANCER AND METASTASIS REVIEWS (2011)
Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
Ines A. Silva et al.
CANCER RESEARCH (2011)
Cancer Stem Cell Niche: The Place to Be
Tijana Borovski et al.
CANCER RESEARCH (2011)
Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line
Jun Dou et al.
CELL BIOLOGY INTERNATIONAL (2011)
Regulation of Mammalian Physiology, Development, and Disease by the Sphingosine 1-Phosphate and Lysophosphatidic Acid Receptors
Victoria A. Blaho et al.
CHEMICAL REVIEWS (2011)
Lysophosphatidic acid-induced expression of periostin in stromal cells: prognoistic relevance of periostin expression in epithelial ovarian cancer
Kyung Un Choi et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Cisplatin Treatment of Primary and Metastatic Epithelial Ovarian Carcinomas Generates Residual Cells With Mesenchymal Stem Cell-Like Profile
Ardian Latifi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Robert A. Burger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells
Jocelyn M. Stewart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1α from human mesenchymal stem cells
Eun Su Jeon et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2010)
Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers
Shan Deng et al.
PLOS ONE (2010)
International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid Receptor Nomenclature
Jerold Chun et al.
PHARMACOLOGICAL REVIEWS (2010)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Two pathways for lysophosphatidic acid production
Junken Aoki et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
Identification and characterization of ovarian cancer-initiating cells from primary human tumors
Shu Zhang et al.
CANCER RESEARCH (2008)
Lysophosphatidic acid induces cell migration through the selective activation of Akt1
Eun Kyoung Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2008)
Lysophosphatidic Acid Receptors Determine Tumorigenicity and Aggressiveness of Ovarian Cancer Cells
Shuangxing Yu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Stem cell regulation by lysophospholipids
Alice Pebay et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells
KRN Baumforth et al.
BLOOD (2005)
Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate
LA van Meeteren et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Translocation of Fas by LPA prevents ovarian cancer cells from anti-Fas-induced apoptosis
YR Meng et al.
GYNECOLOGIC ONCOLOGY (2005)
Ki16425, a subtype-selective antagonist for EDG-Family lysophosphatidic acid receptors
H Ohta et al.
MOLECULAR PHARMACOLOGY (2003)
分享论文
